HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Opalenik, S. R. Articles by Thompson, J. A. Search for Related Content PubMed PubMed Citation Articles by Opalenik, S. R. Articles by Thompson, J. A. Social Bookmarking                      What's this?

Volume 270, Number 29, Issue of July 21, pp. 17457-17467, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

---

(Received for publication, October 21, 1994; and in revised form, May 12, 1995)

From the Division of Transplantation, Department of Surgery, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294

Mounting experimental evidence suggests that the TAT protein, released from human immunodeficiency virus-1 (HIV-1)-infected inflammatory cells, may genetically reprogram targeted cells within a localized environment to develop highly vascularized tumors of mesenchymal origin. The fibroblast growth factor (FGF) family of polypeptides has gained general acceptance as initiators of angiogenesis and functions as potent mitogens for mesoderm-derived cells. To evaluate a potential biological relationship between TAT and acidic FGF (FGF-1), primary murine embryonic fibroblasts either were transfected with the viral transactivator or were transduced (retrovirally mediated) with a secreted, chimeric form of the human polypeptide growth factor, human stomach tumor/Kaposi's sarcoma (hst/KS)FGF-1. Reverse transcriptase-polymerase chain reaction, Western blotting, in situ immunohistochemical, heparin affinity, DNA synthesis, and transient transfection techniques were used to confirm expression, localization, and functionality of the transgenes. Both transfected and transduced cells constitutively expressing either TAT or (hst/KS)FGF-1 adopted a transformed phenotype, maintained aggressive growth behavior, and demonstrated both induction of FGF-specific phosphotyrosyl proteins and nuclear association of FGF-1 and FGF-1 receptor. Increased levels of endogenous, murine FGF-1 mRNA (reverse transcriptase-polymerase chain reaction) and protein (immunoblot analysis) were apparent in both (hst/KS)FGF-1- and TAT-transformed cells. Medium conditioned by (hst/KS)FGF-1-transduced cells contained steady-state levels of biologically active FGF-1 which exhibited a representative molecular weight. Limited sodium dodecyl sulfate-polyacrylamide gel electrophoretic analysis of the conditioned medium from TAT-transformed cells demonstrated the appearance of FGF-1 as latent, high molecular weight complexes requiring reducing agents to activate full biological activity. Collectively, these results suggest that TAT induces the expression and secretion of FGF-1, which may be potentially relevant to the pathophysiological development of AIDS-Kaposi's sarcoma.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				C. Ulich, A. Dunne, E. Parry, C. W. Hooker, R. B. Gaynor, and D. Harrich Functional Domains of Tat Required for Efficient Human Immunodeficiency Virus Type 1 Reverse Transcription J. Virol., March 1, 1999; 73(3): 2499 - 2508. [Abstract] [Full Text]

				M. Rusnati, G. Tulipano, C. Urbinati, E. Tanghetti, R. Giuliani, M. Giacca, M. Ciomei, A. Corallini, and M. Presta The Basic Domain in HIV-1 Tat Protein as a Target for Polysulfonated Heparin-mimicking Extracellular Tat Antagonists J. Biol. Chem., June 26, 1998; 273(26): 16027 - 16037. [Abstract] [Full Text] [PDF]

				S. Dhawan, R. K. Puri, A. Kumar, H. Duplan, J.-M. Masson, and B. B. Aggarwal Human Immunodeficiency Virus-1-Tat Protein Induces the Cell Surface Expression of Endothelial Leukocyte Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, and Intercellular Adhesion Molecule-1 in Human Endothelial Cells Blood, August 15, 1997; 90(4): 1535 - 1544. [Abstract] [Full Text] [PDF]

				M. Rusnati, D. Coltrini, P. Oreste, G. Zoppetti, A. Albini, D. Noonan, F. d'A. di Fagagna, M. Giacca, and M. Presta Interaction of HIV-1 Tat Protein with Heparin. ROLE OF THE BACKBONE STRUCTURE, SULFATION, AND SIZE J. Biol. Chem., April 25, 1997; 272(17): 11313 - 11320. [Abstract] [Full Text] [PDF]

				L. Channavajjala, A Eidsath, and W. Saxinger A simple method for measurement of cell-substrate attachment forces: application to HIV-1 Tat J. Cell Sci., January 1, 1997; 110(2): 249 - 256. [Abstract] [PDF]

				M. Tyagi, M. Rusnati, M. Presta, and M. Giacca Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans J. Biol. Chem., January 26, 2001; 276(5): 3254 - 3261. [Abstract] [Full Text] [PDF]